Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Self-propelled microrockets with drug delivery potential function in acidic environments

Feb. 21, 2012

Novel tissue engineering scaffolds tested in vivo

Feb. 20, 2012

Bioheart gains worldwide rights to adipose stem cell technology

Feb. 17, 2012

Analyte-responsive microscale pumps designed at Penn State

Feb. 16, 2012

Compendia Bioscience enters partnership for next-generation cancer therapeutics

Feb. 15, 2012

Superhydrophobic materials allowing slow drug release designed in U.S.

Feb. 15, 2012

Neuropeptide W/neuropeptide B NPBW1 receptor antagonists described

Feb. 14, 2012

UCB Pharma enters collaboration with Nodality

Feb. 13, 2012

FDA issues draft guidance to assist industry in developing biosimilar products

Feb. 13, 2012

Astrogenetix and NASA enter agreement for drug research in space

Feb. 10, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...